Drug Topics December 2018

Tracking the disease from 2010 to the end of 2018.

The key to job satisfaction lies in your perspective.

Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.

GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management. 

Telepharmacy and expanded services may stem the tide of rural pharmacy closures, but more purchasing power is critical.

Each year, approximately 200,000 children ages 17 years and younger land in emergency departments (EDs) from adverse drug events (ADEs). Children younger than 5 years of age are most likely to visit the ED for ADEs, according to the CDC.

How pharmacists are becoming key members of the ACO model.

4 things that need to happen before pharmacists can expect improvements in compensation. 

Hospital pharmacies are exploring various avenues to mediate the threat of bankruptcy as a result of unsustainable drug costs.

Results from DrugTopics' annual salary survey suggested that salaries, raises, and bonuses fail to improve pharmacists' professional satisfaction. 

CVS vs Amazon, Naxolone, and more. 

Specialty pharmaceuticals make up a significant part of the current drug market, and their impact is only going to grow over the next few years.

A brief interview with Excellus BlueCross BlueShield clinical pharmacist Christopher Diehl on ACOs and managing medication costs.